Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FULC
#4057
Fulcrum Therapeutics, Inc. Common Stock
8.3
8
-3.68%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-3.68%
Mudança mensal
-23.26%
Mudança em 6 meses
+25.26%
Mudança anual
+145.75%
Fechamento anterior
8.7
0
Open
8.3
8
Bid
Ask
Low
8.3
8
High
8.3
8
Volume
82
Mercados
Ações
Cuidados de saúde
FULC
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
32.67 M
40.64 M
61.76 M
61.94 M
53.98 M
66.6 M
—
Valuation ratios
Enterprise value
325.54 M
683.46 M
452.8 M
420.99 M
195.49 M
555.72 M
1.45 B
Price to earnings ratio
—
—
-3.24
-4.53
-29.38
-9.58
-4.91
Price to sales ratio
—
—
0.06
0.16
0
—
—
Price to cash flow ratio
—
—
0
0
0.13
0.01
-0.06
Price to book ratio
—
—
0
0
0
0
0.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.55
0.34
0.48
0.38
0.04
0.2
0.3
Return on equity %
0.74
0.38
0.55
0.41
0.04
0.21
0.31
Return on invested capital %
694.39
255.15
242.06
217.3
41.52
188.47
—
Gross margin %
100
100
100
100
100
—
—
Operating margin %
811.64
422.97
1 774.85
3 945.24
27.37
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
802.66
421.89
1 732.43
3 470.05
12.16
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
4.47
11.77
12.41
17.71
22.63
27.4
98.22
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.03
0.01
0.31
0
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2 157.1
1 483.69
35.78
948.07
270.23
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
780.11
416.95
939.15
3 117.88
3 133.39
Net current asset value per share
—
—
4 612.46
3 950.4
4 032.06
5 642.49
5 719.88
Tangible book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
15.76 K
Working capital per share
—
—
4 240.71
3 727.35
3 853.88
5 436.54
5 510.55
Book value per share
—
—
4 421.82
3 836.13
3 920.92
5 508.64
5 584.08
Notícias
Fulcrum: Strong HbF Signal, Narrow TAM, Same 'Hold' Conclusion (NASDAQ:FULC)
Ações da Fulcrum Therapeutics caem após estudo de anemia falciforme não atingir meta
Fulcrum Therapeutics stock falls as sickle cell trial misses target
Leerink reitera classificação de ações da Fulcrum Therapeutics após dados sobre doença falciforme
Leerink reiterates Fulcrum Therapeutics stock rating on SCD data
BofA reitera classificação Underperform para ações da Fulcrum Therapeutics a US$ 7
BofA reiterates Fulcrum Therapeutics stock Underperform rating at $7
Stifel reafirma classificação das ações da Fulcrum Therapeutics após dados do medicamento
Stifel reiterates Fulcrum Therapeutics stock rating on drug data
Ações da Fulcrum Therapeutics caem por realização de lucros, diz Oppenheimer
Fulcrum Therapeutics shares fall on profit-taking, Oppenheimer says
Ações da Fulcrum Therapeutics caem apesar dos resultados do estudo